Get the latest news on Athersys stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on ATHXQ performance

Latest Athersys Stock News | OTC:ATHXQ | Benzinga

Athersys Inc is a biotechnology company engaged in the field of regenerative medicine. It consists of research, clinical development, manufacturing, and manufacturing process development activities. The firm's main product is Multistem cell therapy. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Comments

Athersys Stock News

News

Latest Athersys Stock News | OTC:ATHXQ | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga